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SUMMARY
In an epidemiological survey from South India, 936 serum samples were tested for IgG against
recombinant baculovirus-expressed VP6 proteins from human group A and group C rotaviruses.
The overall seroprevalence for group A was 100% and for group C was 25.32% (95% CI
22.64–28.21). The lowest seroprevalence for group C was in children aged<10 years (16.79%).
An age-related rise in seroprevalence in group C, but not group A, suggests different patterns
of exposure. Seroprevalence was similar in rural and urban subjects, unlike the higher prevalence
in rural subjects in studies elsewhere.
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INTRODUCTION
Rotaviruses have been known to cause diarrhoeal
illness in humans since they were first identified in
the duodenal mucosa of children afflicted with acute
gastroenteritis [1]. The viruses are typically icosa-
hedral non-enveloped65–75 nmparticles,with a triple-
layered protein capsid enclosing an 11-segment
double-strandedRNAgenome that codes for six struc-
tural (VP1–4, VP6, VP7) and six non-structural (NSP
1–6) proteins [2]. Rotaviruses are classified into seven
groups (A–G) on the basis of reactivity to the epitopes
of the VP6 protein which comprises the middle coat
of the virus [3]. Only groups A, B and C are known
to cause disease in humans, whereas the remaining
four groups are comprised of animal rotaviruses [3].
The group A rotaviruses are the major cause of severe
gastroenteritis in children aged <5 years, resulting
in an estimated 611 000 deaths annually [4]. Group B
rotaviruses have been reported to cause epidemics of
waterborne diarrhoea in China and also cause spor-
adic disease in adults in India [5, 6].
Group C rotaviruses were initially reported in the
USA from young pigs with diarrhoea [7]. Similar
porcine viruses were then identified in Europe and
Australia [8, 9]. Group C rotaviruses were also re-
ported to cause diarrhoea in dogs [10]. Sporadic diar-
rhoeal illness caused by group C rotavirus in humans
has been reported from all continents, in both de-
veloping and developed countries [9, 11–16].
In order to measure exposure to this group of
viruses, early seroepidemiological studies to detect
antibodies to group C rotavirus used reagents de-
rived from the prototype porcine group C rotavirus
‘Cowden strain’ [15, 17, 18]. However, studies on
human group C rotavirus strains have shown that
they are antigenically distinct from their porcine
counterparts [19]. Recent seroepidemiological studies
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have utilized recombinant VP6 protein utilizing genes
from human group C rotavirus strains, produced in
the baculovirus protein expression system [20]. The
prevalence of antibodies against group C rotaviruses
from reported studies have ranged from 3% to 66%
[15, 17, 20–22]. Interestingly, most recent studies have
shown that the prevalence of antibody positivity in-
crease with increasing age with the maximum preva-
lence in samples from septuagenarians [20, 22]. This
study compared seroprevalence of antibodies to
group A and group C rotaviruses in India utilizing
recombinant VP6 proteins.
MATERIALS AND METHODS
Serum samples
Serum samples were collected in a probability pro-
portional to size cluster survey conducted in the
Kaniyambadi block of Vellore district and in the
urban wards of Vellore town from August 1999 to
February 2000 [23]. Briefly, samples from a rural
population comprising of 78 villages in the Kani-
yambadi block of Vellore district in South India and
from an urban population in Vellore municipality
were collected after the selection of households using
cluster sampling. The compliance with sample collec-
tion was 94.8% for the rural population and 87.7%
for the urban population. Serum samples were col-
lected from those aged between 1 and 40 years. To
accommodate the rest of the age strata, samples were
collected from the Biochemistry laboratory at the
Christian Medical College, Vellore, from individuals
aged >40 years who were resident in the geographic
area of the serosurvey. The studies were approved
by the Research Committee of the Christian Medical
College, Vellore.
A separate panel of 20 sera from children known to
have been infected with different rotavirus genotypes
was used to assess three different group A rotavirus
VP6 recombinant antigens prepared as described be-
low. The sera were collected 3–6 weeks post-discharge
from children hospitalized with dehydrating gastro-
enteritis with G1P[8] (n=8), G2P[4] (n=10) and
G10P[11] (n=2).
ELISA
Rotavirus group C VP6 IgG ELISA
All the serum samples were screened for antigroup C
rotavirus IgG antibodies in an ELISA format as
previously described using baculovirus-expressed
recombinant group C VP6 as antigen [22]. Briefly,
96-well microtitre plates (Falcon, USA) were coated
with 100 ml/well of a 1:1000 dilution of rabbit poly-
clonal anti-group C rotavirus VP6 IgG antibodies and
incubated overnight at 4 xC. Wells were washed with
0.01 M phosphate buffered saline–Tween-20 (PBS-T)
and blocked with 200 ml of 5% non-fat milk in PBS
for 1 h at 37 xC. After the blocking step, 100 ng of
recombinant group C rotavirus VP6 protein in 100 ml
of 1% non-fat milk in PBS were added to each well
and incubated for 1 h at 37 xC. The plates were
washed and serum samples diluted to 1:100 in 1%
non-fat milk with PBS-T were added to each well and
incubated for 1 h at 37 xC. The positive control was a
positively tested sample from a previous study [22].
After washing, 100 ml of horseradish peroxidase-
conjugated anti-human IgG goat antibody (Sigma,
India) diluted 1:10 000 in PBS-T was added to the
wells. The plates were incubated for 1 h at 37 xC, wa-
shed with PBS-T, then 100 ml TMB substrate (Sigma)
was added to each well. Finally the reaction was
stopped using 50 ml of 2 M H2SO4 and the optical
density (OD) was read at 450 nm. A test sample was
considered positive when the OD was higher than
three standard deviations of the mean OD of the re-
agent blanks.
Expression of recombinant group A VP6 and ELISA
standardization
The expression and ELISA standardization in a
well-characterized specimen collection is described
in detail in a separate study (Kavanagh et al., un-
published observations). Briefly, the full-length VP6
genes from a G1P[8], a G2P[4] and a G10P[11] strain
from Vellore were PCR amplified, then cloned into
Topo (Invitrogen, USA). The Gateway system
(Invitrogen) using a BP recombination reaction gen-
erated an entry clone, followed by LR recombination
to generate an expression clone in a pDEST10vector
in DH5 alpha-max efficiency cells which was trans-
formed into DH10 Bac competent cells. Bacmid
purification was done using a Power Prep kit (Marli-
gen Biosciences, USA) to isolate the recombinant
bacmid DNA which was then transfected into Sf-9
cells using lipofectamine (Invitrogen). Plaque purifi-
cation was carried to generate P1 stock and the P2
stock was titrated. A time-course experiment was
performed, and 96 h was found to yield the best ex-
pression. The assay was optimized using a chequer-
board titration of all reagents and standardized by
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testing a panel of sera in parallel using IgG estimation
in a modification of a widely used, previously pub-
lished VP6 IgA ELISA, which uses a polyclonal cap-
ture antibody and a virus lysate [24]. The positive
control used in the comparison of the two assays, and
included on each plate with the recombinant protein
assay, was a commercial immunoglobulin preparation
(Iviglob, Vhb Lifesciences Inc., India).
Rotavirus group A VP6 IgG ELISA
Ninety-six-well microtitre plates (Immulon 1B,
Thermo Electron Corporation, USA) were coated
with 1 mg/well of purified group A rotavirus VP6
protein produced by recombinant baculoviruses and
incubated overnight at 4 xC. Wells were washed with
Tris-buffered saline–Tween-20 (TBS-T) and then
blocked with 200 ml of 10% non-fat milk in TBS for
2 h at 37 xC. Serum samples were diluted to 1:200
in TBS-T with 10% non-fat milk added to the
plate and incubated for 2 h at 37 xC. After washing,
horseradish peroxidase-conjugated anti-human IgG
goat antibody (Southern Biotech, UK) diluted
1:10 000 in TBS-T was added. The plates were incu-
bated 1 h at 37 xC, washed with TBS-T and TMB
substrate was added. The reaction was stopped using
1 M H3PO4 and the OD was read at 450 nm. If the OD
of the test sample was three standard deviations
above the mean OD of the blanks it was considered
positive.
Statistical analysis
Data were entered in Microsoft1 Access and ana-
lysed using Graphpad Prism version 4. x2 test was
performed to determine the significance of differences
observed between two groups of subjects.
RESULTS
Prevalence of anti-group C rotavirus VP6 antibody
Of the 936 samples available for analysis, 237 were
positive for anti-group C rotavirus VP6 antibodies
resulting in an overall prevalence of 25.32% (95% CI
22.64–28.21). The prevalence rose from 16.79% in
children aged <10 years to 100% in adults aged
>80 years (Table 1), although smaller numbers were
tested in the older age groups. There was a statistically
significant increase in prevalence of anti-group C
rotavirus VP6 antibodies in the 21–30 years age group
compared to the previous age group of 11–20 years
and between the 61–70 years and the 51–60 years age
groups. Overall, there were no differences by gender.
Rural and urban classification of samples were
available for the 786 samples collected as part of the
population sampling of subjects aged between 1 and
40 years. The results are summarized in Table 2. The
prevalence of anti-group C rotavirus VP6 antibodies
in the rural population aged <40 years was 23.92%
(95% CI 20.38–27.46) and was not different from the
prevalence in the urban population aged <40 years,
which was 21.12% (95% CI 17.73–24.51). The only
age group where the difference was significant be-
tween the two populations was the 1–5 years age
group, where the rural children had higher levels of
antibodies, but this difference was not carried to the
older age groups.
Prevalence of anti-group A rotavirus VP6 antibody
Evaluation of 20 post-infection sera from children
infected with G1P[8], G2P[4] and G10P[11] strains
showed that there was cross-reactivity between the
three antigens, with all 20 samples positive in all
three assays. There was some difference in OD values,
with specific reactivity somewhat higher than cross-
reactive antibodies, but this was not set up as a
quantitative assay.
All 936 samples from the rural and urban collec-
tions were also tested for anti-group A rotavirus VP6
antibody from the G1P[8] strain. Contrary to rota-
virus C, all samples (100%) were positive across all
age groups. The youngest age groups consisting of
Table 1. Seroprevalence by age group of antibodies to
group C rotavirus in South Indian populations using a
recombinant VP6 ELISA
Age group
(yr)
No. of samples
tested
No of samples
seropositive Percentage
1–10 417 70 16.79
11–20 190 50 26.32*
21–30 106 37 34.91
31–40 102 30 29.41
41–50 31 11 35.48
51–60 47 14 29.79
61–70 33 19 57.58#
71–85 10 6 60.0
Total 936 237 25.32
* Values significantly different between the previous group
(P<0.01).
# Values significantly different between the previous group
(P<0.02).
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children between 1 and 10 years in both the rural and
urban populations were universally positive for anti-
bodies against group A rotavirus VP6, suggesting
early exposure to this pathogen.
DISCUSSION
This population-based study from South India found
a prevalence of anti-group C VP6 IgG of 25.32% and
anti-group A VP6 IgG of 100%. A study conducted
in the 1980s found a lower prevalence of anti-group C
rotavirus VP6 antibodies (3%) [15]. The earlier study
used antigen from the prototype porcine ‘Cowden
strain’, unlike the recombinant human rotavirus anti-
gens used in our study and may have missed infec-
tions. Given that in most enteric infections, exposure
in developing countries is higher than in the more in-
dustrialized nations, it is of interest to note that the
prevalence in our study is lower than the prevalences
of 39% and 43% noted in two epidemiological sur-
veys in the UK that also utilized recombinant VP6
antigen [20, 22]. Studies utilizing a similar method-
ology from South Africa and Brazil recorded pre-
valences of 33% and 36%, respectively [25, 26].
A study from Japan utilized a blocking enzyme im-
munoassay and reported a prevalence of 30% [27].
Our study is in accord with the findings of previous
epidemiological surveys that documented an age-
related rise in prevalence of antibodies against group
C rotaviruses [20, 22]. The increase in antibodies with
age suggests a pathogen to which exposure is limited,
unlike group A rotavirus where by the age of 1 year
both urban and rural children demonstrated a history
of rotavirus infection. A serosurvey does not allow
determination of the exact time of exposure, but age-
specific rates permit inference of the degree of ex-
posure over time. Antibody avidity measurements
may also permit estimation of the time since infection;
however, repeated exposure to this virus may also re-
sult in boosting of the immune response resulting in
higher prevalence of antibodies in older individuals.
The possibility of zoonotic spread of rotavirus
group C has been considered based on the results of
a epidemiological survey from the UK in which the
prevalence of antibodies was higher in the rural
population than in the urban populace [22]. This
could be evidence of contact with farm animals where
group C rotaviruses are found. In our study popu-
lation, a higher prevalence was seen in rural children
aged 1–5 years, but not in older children and adults,
suggesting either that transmission is not zoonotic or
that in South India, exposure to potentially infectious
animals is high even in urban populations. The former
is more likely, since human group C rotaviruses are
more conserved and antigenically distinct from ani-
mal strains [19]. Although there were differences be-
tween rural and urban antibody prevalence in the
11–15 and 36–40 years age groups, they did not reach
statistical significance (Table 2), possibly because of
the limited numbers of samples tested in each age
stratum. Antibodies to group A rotavirus were seen
in 100% of our population compared to 85.4% of
children and 97% of adults in a study from the UK
[20]. The lack of correlation of antibodies against
group A and group C rotaviruses suggests that their
transmission patterns are independent of each other,
Table 2. Seroprevalence of antibodies to group C rotavirus in urban and rural South Indian populations
aged between 1 and 40 years
Age
group (yr)
Rural population Urban population
No. of samples
tested
No. of samples
seropositive Percentage
No. of samples
tested
No. of samples
seropositive Percentage
1–5 165 32 19.39 136 12 8.82*
6–10 46 8 17.39 47 10 21.28
11–15 43 6 13.95 51 13 25.49
16–20 47 14 29.79 49 17 34.69
21–25 23 9 39.13 27 10 37.04
26–30 24 9 37.50 32 9 28.13
31–35 25 7 28.00 28 7 25.00
36–40 20 9 45.00 23 5 21.74
Total 393 94 23.92 393 83 21.12
* Values significantly different between rural and urban population in the same age group (P<0.05).
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although it is possible that the age-dependent increase
in reactivity against group C rotavirus VP6 may be
the result of repeated infections with group A rota-
viruses, with re-infecting group A rotavirus strains
eliciting group C cross-reacting antibodies, which
have been described in a previous study [28]. It is
noteworthy that the antibodies against recombinant
proteins produced by cloning and expression of dif-
ferent human (G1P[8], G2P[4]) and animal (G10P[11])
subgroup VP6 appeared to be cross-reactive. How-
ever, an assay based on recombinant proteins, and
one that is set up as a qualitative assay, may also have
other limitations, i.e. the conformation of epitopes
and functionality have not been evaluated.
Group C rotaviruses have been reported as the
cause of diarrhoea epidemics [29–31], and seroepi-
demiological studies have documented exposure [15,
22, 26, 27]. Lack of robust testing methods has pre-
cluded diagnosis of this virus as a cause of diarrhoea
in older children and adults. Systematic prospective
studies are required to document the global distri-
bution of group C rotavirus infection and its role in
causing diarrhoea in humans.
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